Breakthroughs in biotech, medtech, and global logistics

In partnership with

& The TradingPub

Good day, 360! Here are some of our top movers today.

And please join us in Market Masters TODAY at 11AM EST for our special guest, Lance Ippolito. His trading’s been on 🔥. We appreciate your registration → Confirm HERE.

FOCUS LIST🔎

STSS - Up over 75% in the pre-market after announcing beginning of shipments across three customer orders under previously announced purchase agreements 

SGMT - Up over 20% in pre after announcing announcing positive phase 3 results for Denifanstat for the treatment of moderate-to-severe Acne from partner Ascletis 

NCEW - Up over 35% in pre after announcing the proposed acquisition of 51% shares of Asiatic Logistics Limited to deepen its strategic layout in Asia and build a new global logistics ecosystem

HOTLIST🔥

STSS - Up over 75% in the pre-market after announcing beginning of shipments across three customer orders under previously announced purchase agreements 

Sharps Technology Inc. (STSS) is a medical device and pharmaceutical packaging company that engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.

In the pre-market this morning the company announced the initiation of shipments for previously announced purchase orders across three customer orders. These shipments mark the Company’s first deliveries of its SecureGard™ and SoloGard™ product lines and its transition to generating commercial revenue.

Sharps has initiated shipment of its first commercial order of Sologard under a previously announced $50 million supply agreement with a U.S.-based leader in IV flushing solutions. 

The delivery includes customized 10mL SoloGard smart safety syringes manufactured at the Company’s upgraded facility in Hungary. SoloGard is a specialized, FDA- and WHO-approved smart safety syringe featuring ultra-low waste design, standard luer lock compatibility, and re-use prevention technology. This inaugural $400,000 purchase order marks the beginning of a five-year contract to supply up to 500 million syringes and represents the first revenue-generating shipment under the strategic supply agreement.

In a separate shipment, Sharps delivered SecureGard smart safety syringes to a Hungarian vaccine provider following a $100,000 purchase order.

Shares of STSS traded up over 75% in the pre-market in reaction to the news.

The first target for bulls is the pre-market high at $7.66. Beyond that, $8.50 and $10.50 come into play.

Below $7.66, targets to the downside are $6.50, $6, $5.50, $5, $4 and then a gap fill at $3.74.

SGMT - Up over 20% in pre after announcing announcing positive phase 3 results for Denifanstat for the treatment of moderate-to-severe Acne from partner Ascletis 

Sagimet Biosciences Inc. (SGMT) is a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways.

In the after-hours yesterday, the company reported Denifanstat met all primary and secondary endpoints in a Phase 3 clinical trial for the treatment of moderate to severe acne vulgaris conducted by Sagimet’s license partner Ascletis Bioscience Co. Ltd. (Ascletis) in China.

Highlights include:

Denifanstat met all primary and secondary endpoints versus placebo

Denifanstat was well tolerated

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne

Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, that is planned to be developed for acne in the U.S.

Shares of SGMT traded up over 20% in the pre-market in reaction to the news.

The $4.20 area acted as support in the pre-market and will be an important level to watch.

Above it, targets to the upside are $5, $5.50, $5.80, $6 and then the pre-market high at $6.72.

Below $4.20 targets to the downside are $4 and then a gap fill at $3.63.

NCEW - Up over 35% in pre after announcing the proposed acquisition of 51% shares of Asiatic Logistics Limited to deepen its strategic layout in Asia and build a new global logistics ecosystem 

New Century Logistics (BVI) Limited (NCEW) through its subsidiaries, provides freight forwarding services in Hong Kong.

In the pre-market this morning, the company announced has entered into a Letter of Intent ("LOI") with Ms. Chiu Nga Ting, the sole shareholder of Asiatic Logistics Limited, to acquire 51% of the issued and outstanding shares of Asiatic. 

This strategic move is aimed at enhancing New Century's presence in Asia and advancing the development of a comprehensive global logistics ecosystem. 

The signing of the LOI signifies a significant milestone in the ongoing strategic partnership between New Century and Asiatic. It builds upon the existing framework agreement and underscores the mutual commitment to leveraging synergies and optimizing operational efficiencies. 

This acquisition is expected to bolster New Century's core advantages in the Asian market and catalyze the full-chain upgrade of its global logistics network.

Shares of NCEW traded up over 35% in the pre-market in reaction to the news.

The $1.55 area acted as support in the pre-market and will be an important level to watch.

Above it, targets to the upside are $1.65, $2 and then the pre-market high at $2.20. Beyond that, $2.30, $2.50, $3 and $4 come into play.

Below $1.55, targets to the downside are $1.40 and then a gap fill at $1.27 with $1.10 below that.

MARKET NEWS 📰

Don't miss out on our MOBILE ALERTS!  Some of these alerts have rocketed 🚀past the MOON 🌝.  Text “RAGE” to 1-(888) 487-1534 📲.

*Disclosure: By texting “RAGE” to 1-(888) 487-1534, you agree to receive promotional messages sent via an autodialer. You also agree to the terms of service and privacy policy. This agreement isn’t a condition of any purchase. Message frequency varies. Message and data rates may apply. Reply STOP to opt out; HELP for more information.